Global Large Volume Injectors Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Electromechanical Wearable Injector and Others.

By End User;

Hospitals, Clinics, Ambulatory Surgical Centers, and Research Institutes.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn138878644 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Large Volume Injectors Market (USD Million), 2021 - 2031

In the year 2024, the Global Large Volume Injectors Market was valued at USD 3,230.35 million. The size of this market is expected to increase to USD 6,945.01 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 11.6%.

The global market for large volume injectors is witnessing robust growth, driven by the increasing demand for efficient and precise drug delivery systems across various medical and healthcare settings. Large volume injectors, also known as infusion pumps, are medical devices used to administer fluids, medications, and nutrients in large volumes accurately and continuously. They play a critical role in a wide range of medical procedures, including chemotherapy, anesthesia, critical care, and pain management, among others.

One of the primary drivers of the global large volume injectors market is the rising prevalence of chronic diseases and the growing number of surgical procedures worldwide. As the incidence of chronic conditions such as cancer, diabetes, and cardiovascular diseases continues to increase, there is a corresponding rise in the demand for intravenous medications and therapies delivered through large volume injectors. Moreover, the growing aging population and the subsequent increase in the number of surgeries and hospitalizations further contribute to market growth.

Technological advancements and innovations in large volume injector systems are also driving market expansion. Manufacturers are continuously developing advanced infusion pump systems with features such as improved accuracy, precision dosing, user-friendly interfaces, wireless connectivity, and integration with electronic health records. These technological enhancements not only enhance the efficiency and safety of drug delivery but also improve patient comfort and outcomes, driving adoption rates.

The shift towards outpatient and ambulatory care settings is creating new opportunities for the large volume injectors market. With the rising preference for home-based healthcare and the increasing trend towards minimally invasive procedures, there is a growing need for portable, compact, and easy-to-use infusion pump systems that allow patients to receive intravenous therapies outside of traditional hospital settings. This trend is particularly evident in the administration of chemotherapy, pain management, and parenteral nutrition, where patients prefer the convenience and flexibility of home-based treatment options.

The adoption of large volume injectors in emerging markets presents significant growth opportunities for market players. Rapid urbanization, improving healthcare infrastructure, increasing healthcare expenditure, and expanding access to medical technologies are driving demand for infusion pump systems in regions such as Asia-Pacific, Latin America, and Africa. Moreover, government initiatives aimed at improving healthcare access and quality are further fueling market growth in these regions.

In conclusion, the global large volume injectors market is poised for continued growth, driven by factors such as the rising prevalence of chronic diseases, technological advancements, shifting healthcare delivery models, and expanding market reach in emerging economies. As the demand for efficient and precise drug delivery systems continues to rise, large volume injectors will remain indispensable tools in various medical specialties, contributing to improved patient care and outcomes worldwide.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By End User
    3. Market Snapshot, By Region
  4. Global Large Volume Injectors Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Drug Delivery Technology

        2. Preference for Home Healthcare Solutions

        3. Increasing Geriatric Population

        4. Growing number of surgical procedures

      2. Restraints

        1. Limited Reimbursement Policies

        2. Shift towards outpatient care

        3. Complex Regulatory Landscape

        4. Potential Risk of Device Malfunctions

      3. Opportunities
        1. Chronic disease management

        2. Rising healthcare expenditur

        3. Expansion of home healthcare

        4. Collaborations and Partnerships

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Large Volume Injectors Market, By Product, 2021-2031 (USD Million)
      1. Electromechanical Wearable Injector
      2. Others
    2. Global Large Volume Injectors Market, By End User, 2021-2031 (USD Million)
      1. Hospitals
      2. Clinics
      3. Ambulatory Surgical Centers
      4. Research Institutes
    3. Global Large Volume Injectors Market, By Geography, 2021-2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea ASEAN (Association of South East Asian Countries)
        6. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Becton, Dickinson And Company
      2. Insulet Corporation
      3. Tandem Diabetes Care, Inc
      4. Ypsomed Holding Ag
      5. Enable Injections, Inc
      6. Medtronic Plc
      7. Amgen Inc
      8. Gerresheimer Ag (Sensile Medical Ag)
      9. West Pharmaceutical Services, Inc
      10. Cequr Sa
  7. Analyst Views
  8. Future Outlook of the Market